Rectal Misoprostol in Women Undergoing Total Abdominal Hysterectomy for Intraoperative Blood Loss Reduction

• Status: Completed
• Trial end date: 2022-09-26
• Target enrollment: 0
• Participant gender: Female

Summary

Comparing of the intraoperative blood loss between group rectal misoprostol group and control group

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Queen Savang Vadhana Memorial Hospital, Thailand
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

Female undergoing total abdominal hysterectomy (elective case) with

• No history of bleeding tendency

• No history of anticoagulant drug used within 7 days before surgery

• No contraindications of Misoprostol drug used

• No history of allergic to misoprostol

Exclusion Criteria:

• Can not communicate with Thai language

• Malignancy case

• Emergency case